Upgrade to SI Premium - Free Trial

Alnylam Pharmaceuticals (ALNY) PT Lowered to $116 at BMO Capital

November 8, 2018 8:56 AM
BMO Capital analyst Do Kim lowered the price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) to $116.00 (from $124.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change Analyst EPS View Analyst PT Change

Next Articles